AVE Science & Technology Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 24.13%

AVE Science & Technology Co Ltd (688067) has an Asset Resilience Ratio of 24.13% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688067 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥147.54 Million
≈ $21.59 Million USD Cash + Short-term Investments

Total Assets

CN¥611.46 Million
≈ $89.48 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how AVE Science & Technology Co Ltd's Asset Resilience Ratio has changed over time. See shareholders equity of AVE Science & Technology Co Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down AVE Science & Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688067 stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥147.54 Million 24.13%
Total Liquid Assets CN¥147.54 Million 24.13%

Asset Resilience Insights

  • Good Liquidity Position: AVE Science & Technology Co Ltd maintains a healthy 24.13% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

AVE Science & Technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare AVE Science & Technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Caina Technology Co. Ltd.
SHE:301122
Medical Instruments & Supplies 23.52%
Mark Dynamics Indonesia Tbk PT
JK:MARK
Medical Instruments & Supplies 6.64%
GETS Global Bhd
KLSE:5079
Medical Instruments & Supplies 0.03%
QITIAN Technology Group Co Ltd
SHE:300061
Medical Instruments & Supplies 0.00%
Sartorius Aktiengesellschaft
XETRA:SRT3
Medical Instruments & Supplies 4.48%
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
Medical Instruments & Supplies 29.19%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%

Annual Asset Resilience Ratio for AVE Science & Technology Co Ltd (2020–2024)

The table below shows the annual Asset Resilience Ratio data for AVE Science & Technology Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 3.18% CN¥17.86 Million
≈ $2.61 Million
CN¥561.00 Million
≈ $82.09 Million
+2.28pp
2023-12-31 0.90% CN¥5.01 Million
≈ $732.63K
CN¥556.69 Million
≈ $81.46 Million
-22.31pp
2022-12-31 23.21% CN¥127.59 Million
≈ $18.67 Million
CN¥549.65 Million
≈ $80.43 Million
+11.34pp
2021-12-31 11.87% CN¥65.00 Million
≈ $9.51 Million
CN¥547.61 Million
≈ $80.13 Million
+0.07pp
2020-12-31 11.80% CN¥35.00 Million
≈ $5.12 Million
CN¥296.57 Million
≈ $43.40 Million
--
pp = percentage points

About AVE Science & Technology Co Ltd

SHG:688067 China Medical Instruments & Supplies
Market Cap
$282.60 Million
CN¥1.93 Billion CNY
Market Cap Rank
#15208 Global
#4614 in China
Share Price
CN¥28.40
Change (1 day)
+2.05%
52-Week Range
CN¥19.48 - CN¥29.63
All Time High
CN¥37.29
About

AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment China, Europe, the United States, Asia, Africa, and internationally. The company offers urine formed elements analyzer and related reagents, automatic urine ana… Read more